While these data suggest a key role of APP in the development of AD in DS, recent studies from DS models show the important role of APP in the amyloidogenic aspects of AD but challenge the notion that increased APP levels are solely responsible for DS-associated AD pathogenesis (Wiseman et al., 2015, 2018; Ovchinnikov et al., 2018). This evidence concerns the gene APP and Alzheimer disease.